Prevalence of seizures in children infected with human immunodeficiency virus

Journal of Child Neurology

Volumn 28, Issue 3, 2013, Pages 297-302

  Samia, Pauline ^a   Petersen, Reneva ^a   Walker, Kathleen G ^a   Eley, Brian ^a   Wilmshurst, Jo M ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

antiepileptic drugs; antiretroviral; developmental delay; HIV; immunodeficiency; seizures

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CARBAMAZEPINE; DIAZEPAM; EFAVIRENZ; LAMIVUDINE; LAMOTRIGINE; LOPINAVIR; NEVIRAPINE; PHENOBARBITAL; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TOPIRAMATE; VALPROIC ACID;

ARTICLE; BRAIN ATROPHY; BRAIN INFARCTION; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DEVELOPMENTAL DISORDER; DISEASE CONTROL; FAHR DISEASE; FEMALE; FOCAL EPILEPSY; HEARING IMPAIRMENT; HEMIPLEGIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; QUADRIPLEGIA; RISK ASSESSMENT; SEIZURE; TONIC CLONIC SEIZURE; VIRUS LOAD; VISUAL IMPAIRMENT;

ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; MALE; PHENOBARBITAL; PREVALENCE; RETROSPECTIVE STUDIES; SEIZURES; SOUTH AFRICA; VALPROIC ACID;

EID: 84873671666     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073812446161     Document Type: Article

References (37)

1. Power C, Boisse L, Rourke S, Gill MJ. NeuroAIDS: an evolving epidemic. Can J Neurol Sci. 2009 ; 36: 285-295
2. Kellinghaus C, Engbring C, Kovac S, Moddel G, Boesebeck F, Fischera M, et al. Frequency of seizures and epilepsy in neurological HIV-infected patients. Seizure. 2008 ; 17: 27-33 (Pubitemid 350256998)
3. Govender R, Eley B, Walker K, Petersen R, Wilmshurst JM. Neurologic and neurobehavioral sequelae in children with human immunodeficiency virus (HIV-1) infection. J Child Neurol. 2011 ; 26: 1355-1364
4. Sinha S, Satishchandra P, Nalini P, et al. New-onset seizures among HIV infected drug naive patients from south India. Neurol Asia. 2005 ; 10: 25-33
5. Tellechea-Rotta N, Legido A. Acquired immunodeficiency syndrome by vertical transmission: neurological disorders. Rev Neurol. 2003 ; 36: 255-263 (Pubitemid 36565075)
6. Tardieu M, Le Chenadec J, Persoz A, Meyer L, Blanche S, Mayaux MJ. HIV-1-related encephalopathy in infants compared with children and adults. French Pediatric HIV Infection Study and the SEROCO Group. Neurology. 2000 ; 54: 1089-1095 (Pubitemid 30151850)
7. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic; 2010. Available at: http://www.unaids.org/documents/20101123-GlobalReport-em.pdf. Accessed December 3, 2010.
8. van der Weert EM, Hartgers NM, Schaaf HS, et al. Comparison of diagnostic criteria of tuberculous meningitis in human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J. 2006 ; 25: 65-69 (Pubitemid 43361479)
9. Nyasulu P, Cohen C, De Gouveia L, et al. Increased risk of death in human immunodeficiency virus-infected children with pneumococcal meningitis in South Africa, 2003-2005. Pediatr Infect Dis J. 2011 ; 30: 1075-1080
10. Ramos AN, Matida LH, Hearst N, Heukelbach J. Opportunistic illnesses in Brazilian children with AIDS: results from two national cohort studies, 1983-2007. AIDS Res Ther. 2011 ; 8: 23
11. Mung'ala-Odera V, White S, Meehan R, et al. Prevalence, incidence and risk factors of epilepsy in older children in rural Kenya. Seizure. 2008 ; 17: 396-404
12. Mbuba CK, Ngugi AK, Newton CR, Carter JA. The epilepsy treatment gap in developing countries: A systematic review of the magnitude, causes, and intervention strategies. Epilepsia. 2008 ; 49: 1491-1503
13. de Maat MM, Ekhart GC, Huitema AD, Koks CH, Mulder JW, Beijnen JH. Drug interactions between antiretroviral drugs and comedicated agents. Clin Pharmacokinet. 2003 ; 42: 223-282 (Pubitemid 36308064)
14. Romanelli F, Jennings HR, Nath A, Ryan M, Berger J. Therapeutic dilemma: the use of anticonvulsants in HIV-positive individuals. Neurology. 2000 ; 54: 1404-1407 (Pubitemid 30210456)
15. Romanelli F, Ryan M. Seizures in HIV-seropositive individuals: epidemiology and treatment. CNS Drugs. 2002 ; 16: 91-98 (Pubitemid 34155206)
16. Liedtke MD, Lockhart SM, Rathbun RC. Anticonvulsant and antiretroviral interactions. Ann Pharmacother. 2004 ; 38: 482-489 (Pubitemid 38235342)
17. Hugen PW, Burger DM, Brinkman K, et al. Carbamazepine-indinavir interaction causes antiretroviral therapy failure. Ann Pharmacother. 2000 ; 34: 465-470 (Pubitemid 30193777)
18. Sheehan NL, Brouillette MJ, Delisle MS, Allan J. Possible interaction between lopinavir/ritonavir and valproic acid exacerbates bipolar disorder. Ann Pharmacother. 2006 ; 40: 147-150 (Pubitemid 43221489)
19. DiCenzo R, Peterson D, Cruttenden K, et al. Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults. Antimicrob Agents Chemother. 2004 ; 48: 4328-4331 (Pubitemid 39434894)
20. Saraga M, Preisig M, Zullino DF. Reduced valproate plasma levels possible after introduction of efavirenz in a bipolar patient. Bipolar Disord. 2006 ; 8: 415-417 (Pubitemid 44084109)
21. Robertson SM, Penzak SR, Lane J, Pau AK, Mican JM. A potentially significant interaction between efavirenz and phenytoin: A case report and review of the literature. Clin Infect Dis. 2005 ; 41: e15 - e18
22. Berbel GA, Latorre IA, Porta EJ, et al. Protease inhibitor-induced carbamazepine toxicity. Clin Neuropharmacol. 2000 ; 23: 216-218
23. Guberman AH, Besag FM, Brodie MJ, et al. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia. 1999 ; 40: 985-991 (Pubitemid 29316055)
24. Borras-Blasco J, Navarro-Ruiz A, Borras C, Castera E. Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection. J Antimicrob Chemother. 2008 ; 62: 879-888
25. Laughton B The reliability of the adapted Molteno scale in predicting developmental outcomes at 2 years, in prematurely born very low birth weight infants. MSC thesis. Johannesburg: University of Witswaterstand ; 2010
26. The National Antenatal Sentinel HIV and Syphilis Prevalence Survey, South Africa, 2010, National Department of Health. 2010; Available at: http://www.doh.gov.za/docs/reports/2011/hiv-aids-survey.pdf. Accessed March 23, 2012.
27. Carpio A, Hauser WA. Epilepsy in the developing world. Curr Neurol Neurosci Rep. 2009 ; 9: 319-326
28. Christianson AL, Zwane ME, Manga P, Rosen E, Venter A, Kromberg JG. Epilepsy in rural South African children - prevalence, associated disability and management. S Afr Med J. 2000 ; 90: 262-266 (Pubitemid 30214104)
29. Bhigjee AI. Seizures in HIV/AIDS: A southern African perspective. Acta Neurol Scand Suppl. 2005 ; 181: 4-7
30. Udgirkar VS, Tullu MS, Bavdekar SB, Shaharao VB, Kamat JR, Hira PR. Neurological manifestations of HIV infection. Indian Pediatr. 2003 ; 40: 230-234 (Pubitemid 36362629)
31. Tahan TT, Bruck I, Burger M, Cruz CR. Neurological profile and neurodevelopment of 88 children infected with HIV and 84 seroreverter children followed from 1995 to 2002. Braz J Infect Dis. 2006 ; 10: 322-326 (Pubitemid 46443732)
32. Gupta S, Shah DM, Shah I. Neurological disorders in HIV-infected children in India. Ann Trop Paediatr. 2009 ; 29: 177-181
33. Lobato MN, Caldwell MB, Ng P, Oxtoby MJ. Encephalopathy in children with perinatally acquired human immunodeficiency virus infection. Pediatric Spectrum of Disease Clinical Consortium. J Pediatr. 1995 ; 126 (5 pt 1). 710-715
34. Cooper ER, Hanson C, Diaz C, et al. Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection. Women and Infants Transmission Study Group. J Pediatr. 1998 ; 132: 808-812 (Pubitemid 28232931)
35. Shanbhag MC, Rutstein RM, Zaoutis T, Zhao H, Chao D, Radcliffe J. Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy. Arch Pediatr Adolesc Med. 2005 ; 159: 651-656 (Pubitemid 41003088)
36. Abubakar A, Holding P, Newton CR, van Baar A, van de Vijver FJ. The role of weight for age and disease stage in poor psychomotor outcome of HIV-infected children in Kilifi, Kenya. Dev Med Child Neurol. 2009 ; 51: 968-973
37. Domingo P, Suarez-Lozano I, Torres F, et al. Bacterial meningitis in HIV-1-infected patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2009 ; 51: 582-587